The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: The Pacemaker Atrial Fibrillation Suppression (PAFS) study

Europace

Volumn 9, Issue 9, 2007, Pages 790-797

  Sulke, Neil ^a   Silberbauer, John ^a   Boodhoo, Lana ^a   Freemantle, Nick ^b   Kamalvand, Kayvan ^c   O'Nunain, Sean ^d   Hildick Smith, David ^d   Lloyd, Guy W ^a   Patel, Nikhil R ^a   Paul, Vince ^e  

^a EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WILLIAM HARVEY HOSPITAL   (United Kingdom)

^d ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^e ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atrial fibrillation; Detailed onset report; Far field R wave; Paroxysmal atrial fibrillation; Premature atrial contraction

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR PREMATURE BEAT; SYMPTOM; TREATMENT PLANNING;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CROSS-OVER STUDIES; FEMALE; HEART ATRIA; HEART RATE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; TACHYCARDIA, PAROXYSMAL; TREATMENT OUTCOME;

EID: 34548511336     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum111     Document Type: Article

References (34)

1. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T et al. Long term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-16.
2. Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S et al. for the Canadian Trial of Physiological Pacing (CTOPP) Investigators. Canadian trial of physiological pacing. Effects of physiological pacing during long-term follow-up. Circulation 2004;109:357-62.
3. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al., for the Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 2002; 346:1854-62.
4. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SKS et al., for the Pacemaker Selection in the Elderly Investigators. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual chamber pacing. N Engl J Med 1998; 338:1097-104.
5. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005; ?353 145-55.
6. Nielsen JC, Kristensen L, Anderson HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomised comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol 2003;42:614-23.
7. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspan AJ, Freedman RA, Lee KL et al., for the MOde Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pace-maker therapy for sinus node dysfunction. Circulation 2003;107: 2932-37.
8. Gillis AM. Pacing to prevent atrial fibrillation. Cardiol Clin 2000; 18:25-36.
9. Han J, Millet D, Chizzonitti B, Moe GK. Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J 1996;71:481-87.
10. Murgatroyd FD, Nitzsché R, Slade AKB, Limousin M, Rosset N, Camm AJ et al., for the Chorus Multicentre Study Group. A new pacing algorithm for overdrive suppression of atrial fibrillation. Pacing Clin Electrophysiol 1994;17:1966-73.
11. Cappucci A, Santarelli A, Boriani G, Magnani B. Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol 1992;36:87-93.
12. Lam CT, Lau C-P, Leung S-K, Tse H-F, Lee KLF, Tang M-O et al. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2000;2:286-291.
13. Mitchell ARJ, Sulke N. How do atrial pacing algorithms prevent atrial arrhythmias? Europace 2004;6:351-62.
14. Israel CW, Hugl B, Unterberg D, Lawo T, Kennis I, Hettrick D et al. on behalf of the AT500 Verification Study. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-8.
15. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R et al. for the ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol2003 4;41:1926-32.
16. Padeletti L, Pürerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L et al., for the Worldwide ASPECT Investigators. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189-95.
17. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P et al., for the ADOPT Investigators. A new pacemaker algorithm for the treatment of atrial fibrillation. results of the dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol 2003;42:627-33.
18. Wiberg S, Lonnerholm S, Jensen SM, Blomstrom P, Ringqvist I, Blomstrom-Lundqvist C. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: A multicenter randomized study, the PAF-PACE study. PACE 2003;26:1841-8.
19. Puglisi A, Altamura G, Capestro F, Castaldi B, Critelli G, Favale S et al. Impact of closed-loop stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in brady-tachy syndrome. Eur Heart J 2003;24:1952-61.
20. Lee J. Acute testing of the rate-smoothed pacing algorithm for ventricular rate stabilization. PACE 1999;22(Pt. 1):554-61.
21. Yee R. The RASTAF II trial: The effects of ventricular rate stabilization pacing on clinical outcome in atrial fibrillation patients. AHA Scientific Sessions 2003;abstract 2942.
22. Tse H-F, Newman D, Ellenbogen KA, Buhr T, Markowitz T, Lau C-P, for the Worldwide AF SYMPTOMS Investigators. Am J Cardiol 2004;94:939-41.
23. Padeletti L, Santini M, Boriani G, Botto G, Capucci A, Gulizia M et al. Temporal variability of atrial tachyarrhythmia burden in bradycardiatachycardia syndrome patients. Eur Heart J 2005;26:165-72.
24. Carlioz D, Perrier E, Thomas O, Fossati F, Jarwe M, Klug D et al. Accuracy of atrial tachyarrhythmia monitoring in a Selection device: correlation with an external Hotter recording. Europace July 2000; 1(Suppl D):9-10.
25. Jarwe M, Klug D, Marquie C et al. Description of an atrial tachyarrhythmia patient population with a dual chamber pacemaker. Europace 2001;2(Abstract Suppl.):A20.
26. Hoffmann E, Sulke N, Edvardsson N, Ruiter J, Lewalter T, Capucci A et al., on behalf of the Atrial Fibrillation Therapy (AFT) Trial Investigators. New insights into the initiation of atrial fibrillation. A detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. Circulation 2006; 113:1933-41.
27. Veasey R, Silberbauer J, Vrahimides J, Taggu W, Paul V, Sulke N. Do symptoms predict atrial fibrillation episodes in patients with PAF? J Am Coll Cardiol 2006;42:34A.
28. Gold M. The impact of atrial prevention pacing on AF burden: Primary results of the study for atrial fibrillation reduction (SAFARI) trial. Europace 2006;8(Suppl. 1):222-3.
29. Gold MR, Hoffmann E. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: The Study of Atrial Fibrillation Reduction (SAFARI). Am Heart J 2006; 152:231-6.
30. Simpson CS, Yee R, Lee JK, Braney M, Klein GJ, Krahn AD et al. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. Am Heart J 2001; 142 294-300.
31. Marshall HJ, Harris ZI, Griffith MJ, Holder RL, Gammage MD. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: Effects of pacing mode and mode-switch algorithm. Circulation 1999;99:1587-92.
32. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiomi MG et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. Circulation 1997;96:2617-24.
33. Ricci R, Santini M, Padeletti L, Boriani G, Capucci A, Botto G et al. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. J Cardiovasc Electrophysiol 2004; 15:44-51.
34. Warman EN, Grammatico A, Padeletti L. Sample size estimates for atrial fibrillation endpoints. Heart Rhythm 2004;1 (2 Suppl.):B52-62, discussion B63.